Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

1.

Survival in elderly patients supported with continuous flow left ventricular assist device as bridge to transplantation or destination therapy.

Rosenbaum AN, John R, Liao KK, Adatya S, Colvin-Adams MM, Pritzker M, Eckman PM.

J Card Fail. 2014 Mar;20(3):161-7. doi: 10.1016/j.cardfail.2013.12.015. Epub 2014 Jan 9.

PMID:
24412524
[PubMed - in process]
2.

Left ventricular assist devices: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2004;4(3):1-69. Epub 2004 Mar 1.

PMID:
23074453
[PubMed]
Free PMC Article
3.

Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.

John R, Pagani FD, Naka Y, Boyle A, Conte JV, Russell SD, Klodell CT, Milano CA, Rogers J, Farrar DJ, Frazier OH.

J Thorac Cardiovasc Surg. 2010 Jul;140(1):174-81. doi: 10.1016/j.jtcvs.2010.03.037. Epub 2010 May 5.

PMID:
20447659
[PubMed - indexed for MEDLINE]
4.

Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era.

Topkara VK, Kondareddy S, Malik F, Wang IW, Mann DL, Ewald GA, Moazami N.

Ann Thorac Surg. 2010 Oct;90(4):1270-7. doi: 10.1016/j.athoracsur.2010.04.093.

PMID:
20868826
[PubMed - indexed for MEDLINE]
5.

Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.

John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L.

Ann Thorac Surg. 2008 Oct;86(4):1227-34; discussion 1234-5. doi: 10.1016/j.athoracsur.2008.06.030.

PMID:
18805167
[PubMed - indexed for MEDLINE]
6.

Right heart failure and "failure to thrive" after left ventricular assist device: clinical predictors and outcomes.

Baumwol J, Macdonald PS, Keogh AM, Kotlyar E, Spratt P, Jansz P, Hayward CS.

J Heart Lung Transplant. 2011 Aug;30(8):888-95. doi: 10.1016/j.healun.2011.03.006. Epub 2011 Apr 29.

PMID:
21530314
[PubMed - indexed for MEDLINE]
7.

Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.

Kamdar F, John R, Eckman P, Colvin-Adams M, Shumway SJ, Liao K.

J Thorac Cardiovasc Surg. 2013 Feb;145(2):575-81. doi: 10.1016/j.jtcvs.2012.09.095.

PMID:
23321132
[PubMed - indexed for MEDLINE]
8.

Community support of patients with a left ventricular assist device: The Toronto General Hospital experience.

MacIver J, Ross HJ, Delgado DH, Cusimano RJ, Yau TM, Rodger M, Harwood S, Rao V.

Can J Cardiol. 2009 Nov;25(11):e377-81.

PMID:
19898700
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Long-term continuous flow left ventricular assist device support and end-organ function: prospects for destination therapy.

Slaughter MS.

J Card Surg. 2010 Jul;25(4):490-4. doi: 10.1111/j.1540-8191.2010.01075.x. Review.

PMID:
20642766
[PubMed - indexed for MEDLINE]
10.

Comparison of observed survival after ventricular assist device placement versus predicted survival without assist device using the Seattle heart failure model.

Pamboukian SV, Tallaj JA, Brown RN, Nielsen T, George JF, Kirklin JK, Holman WL, Levy WC.

ASAIO J. 2012 Mar-Apr;58(2):93-7. doi: 10.1097/MAT.0b013e31824450f9.

PMID:
22370679
[PubMed - indexed for MEDLINE]
11.

Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.

Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, Rogers JG, Naka Y, Mancini D, Miller LW.

Circulation. 2007 Jul 31;116(5):497-505. Epub 2007 Jul 16.

PMID:
17638928
[PubMed - indexed for MEDLINE]
Free Article
12.

Continuous-flow left ventricular assist device implantation as a bridge to transplantation or destination therapy: racial disparities in outcomes.

Tsiouris A, Brewer RJ, Borgi J, Nemeh H, Paone G, Morgan JA.

J Heart Lung Transplant. 2013 Mar;32(3):299-304. doi: 10.1016/j.healun.2012.11.017. Epub 2012 Dec 21.

PMID:
23265907
[PubMed - indexed for MEDLINE]
13.

Outcomes after implantation of 139 full-support continuous-flow left ventricular assist devices as a bridge to transplantation.

Sabashnikov A, Mohite PN, Weymann A, Patil NP, Hedger M, Sáez DG, Zych B, Wahlers T, Wippermann J, De Robertis F, Bahrami T, Amrani M, Simon AR, Popov AF.

Eur J Cardiothorac Surg. 2014 Sep 1. pii: ezu325. [Epub ahead of print]

PMID:
25180072
[PubMed - as supplied by publisher]
14.

Device exchange after primary left ventricular assist device implantation: indications and outcomes.

Stulak JM, Cowger J, Haft JW, Romano MA, Aaronson KD, Pagani FD.

Ann Thorac Surg. 2013 Apr;95(4):1262-7; discussion 1267-8. doi: 10.1016/j.athoracsur.2012.08.031. Epub 2012 Oct 11.

PMID:
23063192
[PubMed - indexed for MEDLINE]
15.

Left ventricular assist device destination therapy versus extended criteria cardiac transplant.

Daneshmand MA, Rajagopal K, Lima B, Khorram N, Blue LJ, Lodge AJ, Hernandez AF, Rogers JG, Milano CA.

Ann Thorac Surg. 2010 Apr;89(4):1205-9; discussion 1210. doi: 10.1016/j.athoracsur.2009.12.058.

PMID:
20338335
[PubMed - indexed for MEDLINE]
16.

The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.

Clegg AJ, Scott DA, Loveman E, Colquitt J, Hutchinson J, Royle P, Bryant J.

Health Technol Assess. 2005 Nov;9(45):1-132, iii-iv. Review.

PMID:
16303098
[PubMed - indexed for MEDLINE]
Free Article
17.

Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients.

Kamdar F, Boyle A, Liao K, Colvin-adams M, Joyce L, John R.

J Heart Lung Transplant. 2009 Apr;28(4):352-9. doi: 10.1016/j.healun.2009.01.005.

PMID:
19332262
[PubMed - indexed for MEDLINE]
18.

Left ventricular reverse remodeling with a continuous flow left ventricular assist device measured by left ventricular end-diastolic dimensions and severity of mitral regurgitation.

Morgan JA, Brewer RJ, Nemeh HW, Murthy R, Williams CT, Lanfear DE, Tita C, Paone G.

ASAIO J. 2012 Nov-Dec;58(6):574-7. doi: 10.1097/MAT.0b013e31826e4267.

PMID:
23103696
[PubMed - indexed for MEDLINE]
19.

Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device.

Pagani FD, Miller LW, Russell SD, Aaronson KD, John R, Boyle AJ, Conte JV, Bogaev RC, MacGillivray TE, Naka Y, Mancini D, Massey HT, Chen L, Klodell CT, Aranda JM, Moazami N, Ewald GA, Farrar DJ, Frazier OH; HeartMate II Investigators.

J Am Coll Cardiol. 2009 Jul 21;54(4):312-21. doi: 10.1016/j.jacc.2009.03.055.

PMID:
19608028
[PubMed - indexed for MEDLINE]
Free Article
20.

Can the Seattle heart failure model be used to risk-stratify heart failure patients for potential left ventricular assist device therapy?

Levy WC, Mozaffarian D, Linker DT, Farrar DJ, Miller LW; REMATCH Investigators.

J Heart Lung Transplant. 2009 Mar;28(3):231-6. doi: 10.1016/j.healun.2008.12.015.

PMID:
19285613
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk